[Urokinase treatment of threatened and acute myocardial infarct].
D000328:Adult; D000368:Aged; D010450:Endopeptidases / Q000627:therapeutic use*; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000517:prevention & control; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D005340:Fibrinogen; D006493:Heparin; D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator
Traitement par l'urokinase du syndrome de menace et de l'infarctus du myocarde à sa phase aiguë